Cargando…
DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future Directions
In the recent years, there has been significant transformation in the management of valvular heart disease (VHD), as a result of new minimally invasive technologies, such as the transcatheter aortic valve implantation (TAVI). Conventionally, mechanical heart valves require anticoagulation with warfa...
Autores principales: | Ryu, Rachel, Tran, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163724/ https://www.ncbi.nlm.nih.gov/pubmed/35642259 http://dx.doi.org/10.1177/10760296221103578 |
Ejemplares similares
-
An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
por: Cao, Yalin, et al.
Publicado: (2022) -
The future of bioprosthetic heart valves
por: Manji, Rizwan A., et al.
Publicado: (2012) -
DOACs in the Anticoagulation of Mechanical Valves: A Systematic Review and Future Perspectives
por: Langenaeken, Tom, et al.
Publicado: (2023) -
Mechanisms and Drug Therapies of Bioprosthetic Heart Valve Calcification
por: Wen, Shuyu, et al.
Publicado: (2022) -
Bioprosthetic Valve Thrombosis in Carcinoid Heart Disease
por: Hollander, Kimberly Naden, et al.
Publicado: (2019)